BiomX PHGE Income Statement (2018-2026)

NYSE PHGE
$0.14 +0.00 (+0.95%)
As of: Aug 20, 2026 · 3:57 PM EDT
1Y3Y5Y7Y10YAll
Download Data
Income Statement Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating items
Amortization - Intangibles (Quarter)
0.38M0.38M0.38M0.38M0.38M0.38M0.38M
Research & Development (Quarter)
3.82M6.61M6.57M4.93M4.58M3.54M3.19M4.56M3.82M5.64M-12.90M6.90M0.85M6.38M5.25M5.01M0.28M19.65M-0.32M
Selling, General & Administrative (Quarter)
3.10M2.85M2.83M2.48M2.36M2.63M1.99M1.64M2.25M2.15M2.60M2.83M3.25M3.02M2.51M2.42M2.41M2.29M1.61M
Restructuring Costs (Quarter)
0.45M0.19M0.26M0.19M
Other Operating Expenses (Quarter)
-5.64M-6.51M-4.53M
Operating Expenses (Quarter)
6.92M9.90M9.40M7.41M7.14M6.43M5.18M0.56M6.26M7.79M-10.30M9.72M-2.41M9.40M7.76M7.43M-1.84M21.94M1.30M
Operating Income (Quarter)
-7.30M-9.83M-9.79M-7.79M-7.32M-6.55M-5.56M-6.21M-6.07M-7.79M-5.27M-9.72M-11.33M-16.68M-7.76M-7.43M-8.54M-17.74M-1.30M
EBIT (Quarter)
-7.30M-9.83M-9.79M-7.79M-7.32M-6.55M-5.56M-6.21M-6.07M-7.79M-5.27M-9.72M-11.33M-16.68M-7.76M-7.43M-8.54M-17.74M-1.30M
Non-operating items
Non Operating Investment Income (Quarter)
1.86M
Interest & Investment Income (Quarter)
-0.03M-0.02M-0.09M0.09M0.34M0.28M
Other Non Operating Income (Quarter)
0.09M0.34M0.28M0.20M0.33M0.33M0.38M0.21M0.91M-0.38M
Non Operating Income (Quarter)
0.33M0.38M-2.16M0.33M0.33M0.18M-0.03M0.08M0.02M
Net income details
EBT (Quarter)
-7.33M-10.02M-10.41M-8.16M-7.47M-6.77M15.76M-6.36M-6.40M-7.90M-5.49M4.48M9.64M6.71M-7.66M-6.04M-9.16M10.71M-19.14M
Tax Provisions (Quarter)
0.00M0.01M0.05M0.01M0.01M0.01M0.39M0.01M0.01M0.01M0.00M0.01M-3.73M0.00M0.00M0.00M-7.61M
Profit After Tax (Quarter)
-7.34M-10.03M-10.46M-8.17M-7.48M-6.78M-5.89M-6.36M-6.41M7.91M-5.49M4.47M9.64M-14.51M-7.66M-6.04M-9.17M-43.02M-19.14M
Income from Continuing Operations (Quarter)
-7.34M-10.03M-10.46M-8.17M-7.48M-6.78M15.38M-6.36M-6.41M-7.91M-5.49M4.47M9.64M10.45M-7.66M-6.04M-9.17M18.32M-19.14M
Consolidated Net Income (Quarter)
-7.34M-10.03M-10.46M-8.17M-7.48M-6.78M15.38M-6.36M-6.41M-7.91M-5.49M4.47M9.64M10.45M-7.66M-6.04M-9.17M18.32M-19.14M
Income towards Parent Company (Quarter)
-7.34M-10.03M-10.46M-8.17M-7.48M-6.78M15.38M-6.36M-6.41M-7.91M-5.49M4.47M9.64M10.45M-7.66M-6.04M-9.17M18.32M-19.14M
Net Income towards Common Stockholders (Quarter)
-7.34M-10.03M-10.46M-8.17M-7.48M-6.78M15.38M-6.36M6.41M7.91M-46.85M-0.95M-5.07M-20.94M7.66M6.04M9.17M18.32M19.23M
Additional items
EPS (Basic) (Quarter)
-57.31-70.39-76.40-52.17-47.75-43.0797.85-37.6223.6324.79-173.41-2.60-5.88-33.106.303.665.5511.237.38
EPS (Diluted) (Quarter)
-57.31-70.39-76.40-52.17-47.75-43.0797.85-37.6223.6324.79-173.41-1.69-5.87-30.296.303.665.5511.237.38
Shares Outstanding (Quarter)
0.13M0.14M0.14M0.16M0.16M0.16M0.16M0.17M0.27M0.32M0.27M0.27M0.37M0.86M0.63M1.22M1.65M1.65M1.63M2.60M
Shares Outstanding (Diluted) (Quarter)
0.13M0.14M0.14M0.16M0.16M0.16M0.16M0.17M0.27M0.32M0.27M0.27M0.57M0.86M0.69M1.22M1.65M1.65M1.63M2.60M
Shares Outstanding (Entity) (Quarter)
0.13M0.15M0.16M0.16M0.16M0.16M0.16M0.17M0.24M0.32M0.24M0.57M0.37M0.96M0.63M1.31M1.39M1.41M1.59M2.60M
EBITDA (Quarter)
-7.30M-9.83M-9.79M-7.79M-7.32M-6.55M-5.56M-6.21M-6.07M-7.79M-5.27M-9.72M-11.33M-16.68M-7.76M-7.43M-8.54M-17.74M-1.30M
Interest Expenses (Quarter)
4.46M0.83M0.98M0.49M0.56M0.05M0.56M0.74M0.57M0.52M0.57M0.02M0.10M0.01M0.01M0.01M0.01M0.19M
Tax Rate (Quarter)
-0.04%-0.10%-0.49%-0.11%-0.12%-0.12%2.44%-0.09%-0.12%-0.10%-0.02%0.11%-55.55%-0.01%-0.03%-0.03%-71.01%